Nano Lett:纳米酶催化肿瘤光声成像研究获进展

2018-12-18 佚名 生物物理研究所

近日,Nano Letters 杂志在线发表了类外泌体纳米酶小体催化肿瘤光声成像的最新研究成果。研究人员首次利用纳米酶的酶学催化特性,实现了鼻咽癌移植瘤的光声成像。

近日,Nano Letters 杂志在线发表了类外泌体纳米酶小体催化肿瘤光声成像的最新研究成果。研究人员首次利用纳米酶的酶学催化特性,实现了鼻咽癌移植瘤的光声成像。

光声成像结合了纯光学成像的高对比度和纯超声成像的高穿透深度优点,能够提供高对比度和高分辨率的组织成像,是目前非常有应用前景的一种成像模式。光声成像造影剂是决定光声成像性能的关键,它通过改变病灶组织的光学和声学特性,提高成像对比度和分辨率,成为当前生物影像学领域的研究热点。目前,光声成像应用的难点在于设计在肿瘤部位发生的响应型光声成像反应体系。

利用肿瘤微环境的特征是设计肿瘤响应型反应体系的关键。肿瘤代谢具有与正常组织不同的特征,例如,肿瘤区域呈弱酸性,肿瘤细胞会积累大量的H2O2。研究人员针对肿瘤微环境的特点,设计合成了具有高催化活性的石墨烯量子点纳米酶,将底物连氮二铵盐(ABTS)自组装到纳米酶上。为了使纳米酶-底物复合体获得鼻咽癌靶向性,延长纳米酶在体内的血液循环时间,设计了叶酸修饰的红细胞膜,将纳米酶-底物复合体包裹于膜内,创制出类外泌体纳米酶小体。进入血液循环的类外泌体纳米酶小体在外膜的导向下,最终定位并进入肿瘤部位,并释放纳米酶及其底物。肿瘤部位弱酸性环境和高浓度的H2O2触发纳米酶活性,高效催化其底物ABTS转化成氧化型ABTS。后者具有很强的近红外光吸收能力,吸收光能后释放热能导致肿瘤组织局部温度升高,从而导致热膨胀而发出压力波,产生光声信号。通过探测光声信号能重建出组织中的光吸收分布图像,实现肿瘤的光声成像诊断。该研究为肿瘤部位响应型光声成像设计提供了一个实例,为鼻咽癌的诊断提供了一种新思路和新技术。

该研究由中国科学院生物物理研究所阎锡蕴课题组与深圳市第二人民医院聂国辉课题组合作完成。该研究获得深圳市三名工程项目、中科院先导专项、国家科技重大专项、国家自然科学基金、青年人才托举工程等的资助。

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1814410, encodeId=4d831814410c2, content=<a href='/topic/show?id=a6759556121' target=_blank style='color:#2F92EE;'>#酶催化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95561, encryptionId=a6759556121, topicName=酶催化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Tue Feb 05 08:41:00 CST 2019, time=2019-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655142, encodeId=b0a8165514233, content=<a href='/topic/show?id=77b1e7466c0' target=_blank style='color:#2F92EE;'>#纳米酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77466, encryptionId=77b1e7466c0, topicName=纳米酶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=914524650085, createdName=photoman, createdTime=Sat Jul 13 07:41:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801248, encodeId=45df1801248a0, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Tue Jan 29 19:41:00 CST 2019, time=2019-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018329, encodeId=f1df201832947, content=<a href='/topic/show?id=ff8d28e5422' target=_blank style='color:#2F92EE;'>#光声成像#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28754, encryptionId=ff8d28e5422, topicName=光声成像)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512d422, createdName=canlab, createdTime=Fri Feb 22 12:41:00 CST 2019, time=2019-02-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1814410, encodeId=4d831814410c2, content=<a href='/topic/show?id=a6759556121' target=_blank style='color:#2F92EE;'>#酶催化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95561, encryptionId=a6759556121, topicName=酶催化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Tue Feb 05 08:41:00 CST 2019, time=2019-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655142, encodeId=b0a8165514233, content=<a href='/topic/show?id=77b1e7466c0' target=_blank style='color:#2F92EE;'>#纳米酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77466, encryptionId=77b1e7466c0, topicName=纳米酶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=914524650085, createdName=photoman, createdTime=Sat Jul 13 07:41:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801248, encodeId=45df1801248a0, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Tue Jan 29 19:41:00 CST 2019, time=2019-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018329, encodeId=f1df201832947, content=<a href='/topic/show?id=ff8d28e5422' target=_blank style='color:#2F92EE;'>#光声成像#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28754, encryptionId=ff8d28e5422, topicName=光声成像)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512d422, createdName=canlab, createdTime=Fri Feb 22 12:41:00 CST 2019, time=2019-02-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1814410, encodeId=4d831814410c2, content=<a href='/topic/show?id=a6759556121' target=_blank style='color:#2F92EE;'>#酶催化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95561, encryptionId=a6759556121, topicName=酶催化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Tue Feb 05 08:41:00 CST 2019, time=2019-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655142, encodeId=b0a8165514233, content=<a href='/topic/show?id=77b1e7466c0' target=_blank style='color:#2F92EE;'>#纳米酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77466, encryptionId=77b1e7466c0, topicName=纳米酶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=914524650085, createdName=photoman, createdTime=Sat Jul 13 07:41:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801248, encodeId=45df1801248a0, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Tue Jan 29 19:41:00 CST 2019, time=2019-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018329, encodeId=f1df201832947, content=<a href='/topic/show?id=ff8d28e5422' target=_blank style='color:#2F92EE;'>#光声成像#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28754, encryptionId=ff8d28e5422, topicName=光声成像)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512d422, createdName=canlab, createdTime=Fri Feb 22 12:41:00 CST 2019, time=2019-02-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1814410, encodeId=4d831814410c2, content=<a href='/topic/show?id=a6759556121' target=_blank style='color:#2F92EE;'>#酶催化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95561, encryptionId=a6759556121, topicName=酶催化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Tue Feb 05 08:41:00 CST 2019, time=2019-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655142, encodeId=b0a8165514233, content=<a href='/topic/show?id=77b1e7466c0' target=_blank style='color:#2F92EE;'>#纳米酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77466, encryptionId=77b1e7466c0, topicName=纳米酶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=914524650085, createdName=photoman, createdTime=Sat Jul 13 07:41:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801248, encodeId=45df1801248a0, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Tue Jan 29 19:41:00 CST 2019, time=2019-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018329, encodeId=f1df201832947, content=<a href='/topic/show?id=ff8d28e5422' target=_blank style='color:#2F92EE;'>#光声成像#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28754, encryptionId=ff8d28e5422, topicName=光声成像)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512d422, createdName=canlab, createdTime=Fri Feb 22 12:41:00 CST 2019, time=2019-02-22, status=1, ipAttribution=)]

相关资讯

鼻咽癌放疗后视力下降?当心辐射性眼损伤!

鼻咽癌是我国高发恶性肿瘤之一。特别高发于广东地区,很多朋友戏称它为“广东癌”。鼻咽癌大多对放射治疗具有中度敏感性,放射治疗是目前鼻咽癌的首选治疗方法。

探案:癌症患者抗PD-1治疗后高热,病因罕见,疗效意外!

主诉:发现鼻咽癌伴淋巴结转移2月,肿瘤免疫治疗后6天,发热3天

Lancet Oncol:中山大学张力团队鼻咽癌免疫治疗研究获突破

记者从中山大学肿瘤防治中心获悉,该中心张力教授团队牵头开展的鼻咽癌免疫治疗研究取得重大突破。相关研究9月11日以快审通道的形式发表于《柳叶刀?肿瘤学》。香港大学教授Dora L W Kwong在同期评论中指出,这是迄今为止在鼻咽癌领域报道免疫治疗疗效最好的研究。

Cancer Res:这么神奇?中山大学首次发现鼻咽癌易感基因在体内的这种新功能

2018年7月1日,中山大学肿瘤防治中心的曾益新和冯琳课题组研究人员在Cancer Research上发表了题为“TNFRSF19 Inhibits TGFβ Signaling through Interaction with TGFβ Receptor Type I to Promote Tumorigenesis”的研究论文,报道了鼻咽癌易感基因TNFRSF19的体内功能和分子机制。该文章首

Neurology:斜坡后硬膜下血肿所致Godtfredsen综合征

30岁女性,表现为突发头痛2天。由于心脏机械瓣膜植入,患者每天服用华法林7.5mg(国际标准化比值3.5)。

ANN ONCOL:诱导化疗后序贯同步放化疗治疗鼻咽癌

治疗局部晚期鼻咽癌(NPC)时,同步放化疗(CCRT)效果优于单独放疗。加入诱导化疗(IC)是否可以进一步改善治疗效果尚需研究。ANN ONCOL近期发表了一篇文章研究这一问题。